All recalls7,877 total
cGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA recommended interim limit.
cGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA recommended interim limit.
cGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA recommended interim limit.
cGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA recommended interim limit.
cGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA recommended interim limit.
cGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA recommended interim limit.
Product may be contaminated with mold.
The firm received complaints of a "rancid taste" from consumers.
Defective Delivery System: The product does not meet predetermined specifications for Coldflow (adhesive).
Product contains undeclared soy lecithin.
Labeling: Missing Label
potential to be contaminated with Listeria monocytogenes
potential to be contaminated with Listeria monocytogenes
Product contains undeclared hydrolyzed soy protein.
Undeclared allergen - egg
potential to be contaminated with Listeria monocytogenes
Failed Tablet/Capsule Specifications
Defective Container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle
Product contains undeclared sulfites. The product was sampled by the NYSAGM s Food Safety Division and tested positive at 120.7 PPM Sulfites.
Failed Content Uniformity Specifications: Product failed to meet the action limits for stratified content uniformity.
Undeclared wheat. Product contains wheat but was mis-labeled as Savory 6 Cut Crinkle Cut Wedge and label does not declare wheat.
CGMP Deviations: Active pharmaceutical ingredient was sourced from an unapproved vendor
CGMP Deviations: Active pharmaceutical ingredient was sourced from an unapproved vendor
CGMP Deviations: Active pharmaceutical ingredient was sourced from an unapproved vendor
Failed Tablet/Capsule Specifications: Complaints received of crushed and broken tablets.
Failed Tablet/Capsule Specifications: Complaints received of crushed and broken tablets.
Potential contamination of E. coli O157:H7
Potential contamination of E. coli O157:H7
Potentially contaminated with E. coli O157:H7.
Potential contamination of E. coli O157:H7
Potential contamination of E. coli O157:H7
Potentially contaminated with E. coli O157:H7.
The firm was notified after laboratory analysis that the product test positive for Listeria monocytogenes.